benzinga.comEli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst4 days ago
prnewswire.comPACSUN AND SELENA GOMEZ'S RARE IMPACT FUND LAUNCH NEW RARE DNM EDIT COLLECTION FOR SPRING '254 months ago
finance.yahoo.comEditas Medicine to Host Strategic Update Webinar to Detail Progress Towards 2024 Goals, Including Achievement of Establishing In Vivo Preclinical Proof of Concept8 months ago
finance.yahoo.comEditas trades part of Vertex CRISPR therapy licencing rights deal for $57m9 months ago
CashuEli Lilly's Acquisition of Verve Therapeutics: Implications for Editas Medicine and Genetic Therapy2 days ago
CashuEditas Medicine: Eli Lilly Acquires Verve Therapeutics for Cardiovascular Genetic Therapies4 days ago
CashuEditas Medicine: Leading Genetic Innovation Amid Cultural and Ethical Considerations4 months ago